Paid Clinical Trials in San Francisco, CA

Browse 100 Paid Studies San Francisco Across 656 Cities
31 Phase 3 Trial · 3390 Paid Studies San Francisco Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in San Francisco, CA

Reviewed by Michael Gill, B. Sc.

Image of University of Alabama at Birmingham in Birmingham, United States.

10 Paid Studies San Francisco Near Me

Top Cities for Paid Studies San Francisco

San Francisco

122Active Trials

University of California, San FranciscoTop Active Site

New York

86Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site

Paid Studies San Francisco by Phase of Trial

N/A Paid Studies San Francisco

19Active Paid Studies San Francisco

19Number of Unique Treatments

465Number of Active Locations

Screening (biospecimen collection)HIVD+/R+Pembrolizumab Active DBS Telemetric Intervention PushCon Model Cohort A Therapeutic Hypothermia Treatment AccuCinch Ventricular Restoration System Partial Colectomy MiniMed™ 780G system with DS5 Active Whole-body Hyperthermia (Active Treatment)Experimental: TARA Training WeB and pelvic floor physical therapy group TAVR Sulcus tube placement BAGUERA®C Cervical Disc Prosthesis RA Medication summary guide and RA Choice

Most Recent Paid Studies San Francisco

Clinical Trial

Began Recruiting Date

Phase

Sulcus tube placement for Glaucoma

7/11/2023

N/A

Cohort A for Cognition

7/5/2023

N/A

TXA, Saline for Breast Cancer

4/20/2023

Phase 4

Part 1.1: Dose Escalation (Advanced Solid Tumors and Breast) for Breast Cancer

4/17/2023

Phase 1 & 2

WeB and pelvic floor physical therapy group for Multiple Sclerosis

3/15/2023

N/A

About The Author

Michael Gill - B. Sc.

First Published: October 17th, 2021

Last Reviewed: August 9th, 2023

References¹ Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. Review. https://pubmed.ncbi.nlm.nih.gov/31401903² Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. https://pubmed.ncbi.nlm.nih.gov/31401903³ Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients. Cochrane Database Syst Rev. 2022 Sep 12;9:CD012854. doi: 10.1002/14651858.CD012854.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/36094829⁴ Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients. Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2. https://pubmed.ncbi.nlm.nih.gov/36094829⁵ Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001 Aug;39(8):800-12. doi: 10.1097/00005650-200108000-00006. https://pubmed.ncbi.nlm.nih.gov/11468499⁶ Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704. https://pubmed.ncbi.nlm.nih.gov/35622074⁷ Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001 Aug;39(8):800-12. https://pubmed.ncbi.nlm.nih.gov/11468499⁸ Shi Z, Zhu Y, Zhang J, Chen B. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology. 2022 Dec;27(1):642-652. doi: 10.1080/16078454.2022.2074704. Review. https://pubmed.ncbi.nlm.nih.gov/35622074⁹ Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001 Aug;39(8):800-12. https://pubmed.ncbi.nlm.nih.gov/11468499¹⁰ Sandborn WJ, Vermeire S, Tyrrell H, Hassanali A, Lacey S, Tole S, Tatro AR; Etrolizumab Global Steering Committee. Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program. Adv Ther. 2020 Jul;37(7):3417-3431. doi: 10.1007/s12325-020-01366-2. Epub 2020 May 22. https://pubmed.ncbi.nlm.nih.gov/32445184